1. Home
  2. BKU vs AMPH Comparison

BKU vs AMPH Comparison

Compare BKU & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$45.30

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
AMPH
Founded
2009
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.2B
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
BKU
AMPH
Price
$45.30
$26.87
Analyst Decision
Hold
Buy
Analyst Count
11
6
Target Price
$42.73
$31.00
AVG Volume (30 Days)
875.8K
389.3K
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.74%
N/A
EPS Growth
44.85
N/A
EPS
3.54
2.27
Revenue
$1,016,093,000.00
$723,305,000.00
Revenue This Year
$14.68
$1.35
Revenue Next Year
$5.73
$5.10
P/E Ratio
$12.78
$11.81
Revenue Growth
10.45
N/A
52 Week Low
$28.21
$20.39
52 Week High
$46.92
$39.56

Technical Indicators

Market Signals
Indicator
BKU
AMPH
Relative Strength Index (RSI) 62.19 53.61
Support Level $45.03 $26.26
Resistance Level $45.95 $27.44
Average True Range (ATR) 0.89 0.83
MACD -0.22 0.04
Stochastic Oscillator 40.04 71.43

Price Performance

Historical Comparison
BKU
AMPH

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: